ADMA Biologics Reports Third Quarter 2018 Financial Results

Nov 8, 2018

ADMA Biologics Receives PDUFA Date for RI-002

Oct 17, 2018

ADMA Biologics Provides Regulatory Update for BIVIGAM®

Oct 11, 2018

ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center

Oct 3, 2018

ADMA Biologics Resubmits Biologics License Application for RI-002

Oct 1, 2018

ADMA Biologics Reports FDA Compliance Status for its Manufacturing Facility has Improved

Sep 5, 2018

ADMA Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

Aug 27, 2018

ADMA Biologics Reports Second Quarter 2018 Financial Results

Aug 10, 2018

ADMA Biologics Reports Successful Close-Out of its April 2018 FDA Compliance Inspection

Jul 26, 2018

ADMA Biologics Receives PDUFA Date for BIVIGAM® Regulatory Submission

Jul 26, 2018